Evidence map›Paper›PMID 19351909›Full record

ArticlePhysiological genomics2009

Genetic dissection reveals diabetes loci proximal to the gimap5 lymphopenia gene.

J M Fuller, M Bogdani, T D Tupling, R A Jensen, R Pefley, S Manavi, L Cort, E P Blankenhorn, J P Mordes, A Lernmark and 1 more

Open access · greenAbstract read
In one paragraph

Article in Physiological genomics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Quantitative temporal analysis of pancreatic islet T lymphocyte and macrophage infiltration heralded by serum IgE in congenic BioBreeding (BB) Gimap5Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

J M FullerDepartment of Clinical Sciences, Lund University, Clinical Research Center, Malmö, Sweden. jfuller@u.washington.edu
M Bogdani
T D Tupling
R A Jensen
R Pefley
S Manavi
L Cort
E P Blankenhorn
J P Mordes
A Lernmark
A E Kwitek
University of Washington · USDrexel University · USLund University · SEPacific Northwest Diabetes Research Institute · USUniversity of Iowa · USUniversity of Massachusetts Chan Medical School · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1986 to 2026
$41.4M
PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
GENETIC CONTROL OF BB RAT AUTOIMMUNITY.P01AI042380 · NIAID · UNIVERSITY OF WASHINGTON · PI LERNMARK, AKE · 1997 to 2009
$8.2M
CVD Epidemiology Training ProgramT32HL007902 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M · 1998 to 2012
$3.6M
Genetics of Virus-Induced Autoimmunity in BB RatsR01DK066447 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MORDES, JOHN PETER · 2005 to 2007
$718k
NHLBI NIH HHS T32HL-007902NIAID NIH HHS AI-042380NIAID NIH HHS P01 AI042380NIDDK NIH HHS DK-17047NIDDK NIH HHS DK-32520NIDDK NIH HHS R01DK-066447
6 · The paper itself

Abstract

Congenic DRF.(f/f) rats are protected from type 1 diabetes (T1D) by 34 Mb of F344 DNA introgressed proximal to the gimap5 lymphopenia gene. To dissect the genetic factor(s) that confer protection from T1D in the DRF.(f/f) rat line, DRF.(f/f) rats were crossed to inbred BBDR or DR.(lyp/lyp) rats to generate congenic sublines that were genotyped and monitored for T1D, and positional candidate genes were sequenced. All (100%) DR.(lyp/lyp) rats developed T1D by 83 days of age. Reduction of the DRF.(f/f) F344 DNA fragment by 26 Mb (42.52-68.51 Mb) retained complete T1D protection. Further dissection revealed that a 2 Mb interval of F344 DNA (67.41-70.17 Mb) (region 1) resulted in 47% protection and significantly delayed onset (P < 0.001 compared with DR.(lyp/lyp)). Retaining <1 Mb of F344 DNA at the distal end (76.49-76.83 Mb) (region 2) resulted in 28% protection and also delayed onset (P < 0.001 compared with DR.(lyp/lyp)). Comparative analysis of diabetes frequency in the DRF.(f/f) congenic sublines further refined the RNO4 region 1 interval to approximately 670 kb and region 2 to the 340 kb proximal to gimap5. All congenic DRF.(f/f) sublines were prone to low-grade pancreatic mononuclear cell infiltration around ducts and vessels, but <20% of islets in nondiabetic rats showed islet infiltration. Coding sequence analysis revealed TCR Vbeta 8E, 12, and 13 as candidate genes in region 1 and znf467 and atp6v0e2 as candidate genes in region 2. Our results show that spontaneous T1D is controlled by at least two genetic loci 7 Mb apart on rat chromosome 4.

Indexed as

AnimalsDiabetes Mellitus, ExperimentalGTP-Binding ProteinsLymphopeniaRatsGimap5 protein, ratGTP-Binding Proteins

Identifiers

PMID19351909
PMCPMC2696149
OpenAlexW2049622433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.